Congenital erythropoietic porphyria: dilemmas in present day management
- PMID: 12472546
- DOI: 10.1046/j.1365-2230.2002.01166.x
Congenital erythropoietic porphyria: dilemmas in present day management
Abstract
Congenital erythropoietic porphyria is a rare autosomal recessive disorder of haem biosynthesis caused by a deficiency of uroporphyrinogen III synthetase. There is resultant accumulation and hyperexcretion of porphyrinogens of the isomer I variety. These are converted by spontaneous oxidation into their corresponding photoactive porphyrins leading to photodamage. Accumulation of porphyrins results in haemolysis and extensive photosensitivity. The consequences of chronic haemolysis are splenomegaly, reactive erythroid hyperplasia, erythrodontia, bone fragility, extreme photosensitivity and photomutilation. We present a 35-year-old man who has the severe infantile form and illustrates the haematological and photodestructive complications despite attempts at treatment with hypertransfusion, oral charcoal therapy and beta-carotene. Allogenic bone marrow transplantation has been considered but because of the high associated mortality this procedure has been discounted at present in the management of our patient.
Similar articles
-
Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.Blood. 2020 Nov 19;136(21):2457-2468. doi: 10.1182/blood.2020006037. Blood. 2020. PMID: 32678895
-
Congenital erythropoietic porphyria: Recent advances.Mol Genet Metab. 2019 Nov;128(3):288-297. doi: 10.1016/j.ymgme.2018.12.008. Epub 2018 Dec 27. Mol Genet Metab. 2019. PMID: 30685241 Free PMC article. Review.
-
Treatment of congenital erythropoietic porphyria in children by allogeneic stem cell transplantation: a case report and review of the literature.Bone Marrow Transplant. 2001 Jan;27(1):101-5. doi: 10.1038/sj.bmt.1702738. Bone Marrow Transplant. 2001. PMID: 11244446 Review.
-
Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.Pediatr Dermatol. 2013 Jul-Aug;30(4):484-9. doi: 10.1111/pde.12117. Epub 2013 Apr 5. Pediatr Dermatol. 2013. PMID: 23557135
-
Bullous skin lesions in a jaundiced infant after phototherapy: a case of congenital erythropoietic porphyria.Turk J Pediatr. 2013 Mar-Apr;55(2):218-21. Turk J Pediatr. 2013. PMID: 24192686
Cited by
-
Erythrodontia in congenital erythropoietic porphyria.J Oral Maxillofac Pathol. 2011 Jan;15(1):69-73. doi: 10.4103/0973-029X.80022. J Oral Maxillofac Pathol. 2011. PMID: 21731282 Free PMC article.
-
Identification of novel UROS mutations in a patient with congenital erythropoietic porphyria and efficient treatment by phlebotomy.Mol Genet Metab Rep. 2021 Feb 11;27:100722. doi: 10.1016/j.ymgmr.2021.100722. eCollection 2021 Jun. Mol Genet Metab Rep. 2021. PMID: 33659185 Free PMC article.
-
A Case of Congenital Erythropoietic Porphyria without Haemolysis.Eur J Case Rep Intern Med. 2016 Sep 22;3(7):000497. doi: 10.12890/2016_000497. eCollection 2016. Eur J Case Rep Intern Med. 2016. PMID: 30755899 Free PMC article.
-
Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.Am J Hum Genet. 2006 Apr;78(4):645-58. doi: 10.1086/502667. Epub 2006 Feb 9. Am J Hum Genet. 2006. PMID: 16532394 Free PMC article.
-
Bullous lesions following phototherapy in a newborn.Einstein (Sao Paulo). 2023 May 29;21:eRC0256. doi: 10.31744/einstein_journal/2023RC0256. eCollection 2023. Einstein (Sao Paulo). 2023. PMID: 37255061 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources